New hope to relieve dryness and fatigue in Sjögren’s disease Novartis’ iscalimab may improve troubling symptoms in patients with Sjögren’s disease, though there may be safety concerns to address.

https://www.drugdiscoverynews.com/new-hope-to-relieve-dryness-and-fatigue-in-sj-gren-s-disease-16161